Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1097 record(s)

Req # A-2020-000068

Adverse Reaction Report (AER) for DOCUSATE SODIUM. Report number: 000726470.

Organization: Health Canada

3 page(s)
December 2020

Req # A-2020-000073

Adverse Reaction Reports (AERs). Report numbers: E2B_02645175, E2B_02646038 E2B_02647196, E2B_02115045, 000729438.

Organization: Health Canada

83 page(s)
December 2020

Req # A-2020-000074

Adverse Reaction Reports (AERs) for METFORMIN HYDROCHLORIDE. Report numbers: 000725759, 000727705, E2B_02521674, E2B_02527157, E2B_02494049, E2B_02538128, E2B_02557565, E2B_02578431, E2B_02152974, E2B_00593225, E2B_02573709, E2B_02575168, 724874, 725407, 726893, E2B_02586575, E2B_02637919.

Organization: Health Canada

200 page(s)
December 2020

Req # A-2020-000075

Adverse Reaction Reports (AERs) for METRONIDAZOLE. Report numbers: E2B_02637001, E2B_02615126, E2B_02618061, E2B_02535812, E2B_02285297, E2B_02510171, E2B_02532195, E2B_02534673 E2B_02393889, E2B_02564628, E2B_02571761.

Organization: Health Canada

209 page(s)
December 2020

Req # A-2020-000091

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02773221, E2B_02728372, E2B_02728380, E2B_02806518, E2B_02786877, E2B_02796010, E2B_02797568, E2B_02791675, E2B_02787601, E2B_02810156, E2B_02814222, E2B_02728448, E2B_02728449, E2B_02728516, E2B_02728517.

Organization: Health Canada

216 page(s)
December 2020

Req # A-2020-000119

Adverse Reaction Reports (AERs). Report numbers: E2B_02329595, E2B_02329601, E2B_02332753, E2B_02332814, E2B_02332822, E2B_02332824, E2B_02335559, E2B_02336090, E2B_02378377, E2B_02427277, E2B_02428772, E2B_02441931, E2B_02449140, E2B_02450830, E2B_02454633.

Organization: Health Canada

491 page(s)
December 2020

Req # A-2020-000142

Adverse Reaction Reports (AERs). Report numbers: E2B_02966111, E2B_02966170, E2B_02967216, E2B_02967223.

Organization: Health Canada

90 page(s)
December 2020

Req # A-2020-000147

Adverse Reaction Reports (AERs). Report numbers: E2B_02985249, E2B_02987894, E2B_02985739.

Organization: Health Canada

43 page(s)
December 2020

Req # A-2020-000199

Adverse Reaction Reports (AERs). Report numbers: E2B_02562480, E2B_02568526, E2B_02569033, E2B_02582494, E2B_02617874, E2B_02635358, E2B_02636496, E2B_02636497, E2B_02640883, E2B_02643402, E2B_02644533, E2B_02645141, E2B_02645142, E2B_02651943, E2B_02658104, E2B_02658116.

Organization: Health Canada

509 page(s)
December 2020

Req # A-2020-000201

Adverse Reaction Reports (AERs). Report numbers: E2B_02477278, E2B_02611042, E2B_02519859, E2B_02597136, E2B_02631755, E2B_02634449, E2B_02665268, 000729743, E2B_02820523, E2B_02676060, E2B_02637001.

Organization: Health Canada

340 page(s)
December 2020
Date modified: